Best practice in Duchenne muscular dystrophy
Neuromuscul Disord
.
2010 Mar;20(3):217; author reply 218-9.
doi: 10.1016/j.nmd.2010.02.007.
Epub 2010 Mar 4.
Author
Ros Quinlivan
PMID:
20206520
DOI:
10.1016/j.nmd.2010.02.007
No abstract available
Publication types
Comment
Letter
MeSH terms
Adrenal Cortex Hormones / therapeutic use
Benchmarking*
Humans
Muscular Dystrophy, Duchenne / therapy*
Substances
Adrenal Cortex Hormones